Inclusion Criteria:

- Eligible patients must have histologically confirmed solid tumors of advanced stages

- Patients who are suitable for being treated with liposomal paclitaxel only

- Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2

- Patients who are expected to be alive for at least 3 months

- Adequate hematologic, hepatic and renal functions

- Adequate other organ functions as defined by the protocol

- No prior systemic chemotherapy at least 4 weeks before the recruitment

- No previous anaphylactic reaction to hormone.

Exclusion Criteria:

- Allergy to any study medication

- Serious complication that would compromise the patient's ability to complete the
study

- Grade ≥1 neuropathy using NCI CTCAE version 3.0 criteria

- Pregnancy or breast feeding